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ABSTRAK
Penyakit kardiovaskular (CVD) menjadi penyebab utama kematian secara global. Infark miokard akut pada 
orang dewasa muda jarang terjadi. Aterosklerosis adalah penyebab utama CVD, termasuk infark miokard, stroke, 
gagal jantung, dan penyakit arteri perifer. Kondisi ini dimulai sejak dini dan bersifat progresif. Faktor risiko CVD 
termasuk hipertensi, dislipidemia, dan obesitas berperan dalam proses aterosklerosis dan merupakan komponen 
dalam sindrom resistensi insulin.
Salah satu faktor risiko untuk terjadinya resistensi insulin pada orang sehat adalah first degree relative (FDR) 
dari pasien diabetes melitus tipe 2 (T2DM). Kelompok ini menunjukkan risiko resistensi insulin dan gangguan 
sel beta pankreas yang lebih tinggi bahkan pada masa remaja, walaupun asimtomatik. Manifestasi klinis dari 
gangguan metabolik dan aterosklerosis akan muncul lebih awal pada kelompok FDR T2DM yang memiliki pola 
hidup sedentari dan obesitas, jika dibandingkan dengan kelompok non-FDR. Beberapa penelitian sudah berusaha 
untuk mendeteksi gangguan metabolik dan aterosklerosis subklinis yang mungkin terjadi; oleh karena itu pencegahan 
dini dapat dilakukan pada kelompok berisiko tinggi ini. Sayangnya, faktor-faktor yang memengaruhi onset dan 
tingkat keparahan manifestasi klinis yang akan terjadi selanjutnya dari studi-studi  sebelumnya masih belum jelas. 
Kata kunci: penyakit kardiovaskular, aterosklerosis, first-degree relative, diabetes melitus tipe 2.
ABSTRACT
Cardiovascular disease (CVD) remain a leading cause of death globally. The concept of acute myocardial 
infarction in young adults was uncommon. Atherosclerosis is the leading cause of CVD, including myocardial 
infarction, stroke, heart failure and peripheral artery disease. This condition is initiated early in childhood 
and progressive in nature. CVD risk factors includes hypertension, dyslipidemia and obesity play a role in the 
development of atherosclerosis and  components in insulin resistance syndrome.
One of many risk factors for insulin resistance in healthy individuals is a first-degree relative (FDR) of Type 2 
Diabetes Mellitus (T2DM) patients. This group shows a higher risk of insulin resistance and pancreatic beta cells 
disruption even in adolescence, although they often remains asymptomatic. Clinical manifestations of metabolic 
disorders and atherosclerosis will appear earlier in the FDR T2DM group who have sedentary lifestyles and 
obesity, when compared to the non-FDR group. Several studies have attempted to detect metabolic disorders and 
subclinical atherosclerosis that might occur; therefore an early prevention can be carried out in these high-risk 
groups.  Unfortunately, factors that affect the onset and the severity of the prospective clinical manifestations from 
the previous studies remained inconclusive.
Keywords: cardiovascular disease, atherosclerosis, first-degree relative, type 2 diabetes mellitus.
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INTRODUCTION
Cardiovascular disease (CVD) remain 
a leading cause of death globally. In 2013, 
approximately 17.3 million out of 54 million 
of total death per year was caused by CVD.1 
Based on a WHO report in 2014, CVD ranked 
as the leading cause of death in Indonesia, at an 
approximate of 37% of all causes of death.2 The 
concept of acute myocardial infarction in young 
adults was uncommon. A study by Mahle, et al.3 
reported that only 5% of total number of acute 
coronary syndromes constituted of individuals 
younger than 40 years. A study by Rithza, et al.4 
described that the number of patients younger 
than 45 years old who suffered from acute 
coronary syndrome were 101 cases.
Atherosclerosis is the leading cause of 
CVD, including myocardial infarction, stroke, 
heart failure and peripheral artery disease. This 
condition is initiated early in childhood and 
progressive in nature. Atherosclerosis remains 
asymptomatic for the first few decades before 
becoming clinically manifested. This condition 
is known as subclinical atherosclerosis.5 CVD 
risk factors includes hypertension, dyslipidemia 
and obesity play a role in the development of 
atherosclerosis and  components in insulin 
resistance syndrome.6
One of many risk factors for insulin resistance 
in healthy individuals is a first-degree relative 
(FDR) of Type 2 Diabetes Mellitus (T2DM) 
patients. This group shows a higher risk of insulin 
resistance and pancreatic beta cells disruption 
even in adolescence, although they often 
remains asymptomatic.7 Clinical manifestations 
of metabolic disorders and atherosclerosis will 
appear earlier in the FDR T2DM group who 
have sedentary lifestyles and obesity, when 
compared to the non-FDR group. Several studies 
have attempted to detect metabolic disorders 
and subclinical atherosclerosis that might occur; 
therefore an early prevention can be carried 
out in these high-risk groups. Unfortunately, 
factors that affect the onset and the severity of 
the prospective clinical manifestations from the 
previous studies remained inconclusive.
AT H E R O S C L E R O S I S  A N D I N S U L I N 
RESISTANCE
Atherosclerosis is a chronic systemic 
inflammatory process that is related to the 
elasticity of a blood vessel. It remains as the 
main cause of cardiovascular diseases such as 
coronary heart disease and stroke. Blood vessels 
that are often affected include large blood vessels 
(aortic, carotid, iliac arteries) and moderate blood 
vessels (coronary arteries and popliteal arteries).8
The cause of atherosclerosis is not fully 
established yet. Several previous studies 
have shown that atherosclerosis arises due to 
endothelial dysfunction that causes structural 
changes in the arterial wall which result in 
thickening and stiffening of blood vessels.9 
Endothelial dysfunction occurs due to several 
factors, such as hypertension, increased low 
density lipoprotein (LDL) concentration, toxic 
effects of cigarette, high density lipoprotein 
(HDL) transportation dysfunction, and insulin 
resistance. This process will reduce the 
production of nitric oxide (NO) ultimately 
resulting in endothelial dysfunction.10
In T2DM, the process of atherosclerosis 
has occurred in the phase of insulin resistance, 
which precedes the onset of hyperglycemia, 
thus resulting in advanced cardiovascular 
complications.  Insulin resistance is  a 
condition of the inability of insulin to produce 
biological effects, including effects on glucose 
metabolism, protein, and lipids and to regulate 
blood vessel function. Hyperinsulinemia 
is the body’s compensation mechanism to 
prevent hyperglycemia. Hyperinsulinemia 
increases the individuals’ risk to develop 
glucose intolerance, increase triglyceride 
levels, decrease HDL cholesterol levels, and 
hypertension.11 Hyperinsulinemia accompanied 
by hyperglycemia and dyslipidemia will 
increase the progression risk of atherosclerosis, 
which in turn will increase the risk of CVD.12 
The pathophysiology of insulin resistance and 
atherosclerosis can be seen in Figure 1.
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Figure 1. The pathophysiology of atherosclerosis in diabetes mellitus12
INSULIN RESISTANCE IN POPULATION 
WITH FIRST-DEGREE RELATIVES OF TYPE 
2 DIABETES MELLITUS
Studies in twins indicate that insulin resistance 
is influenced by genetic and environmental 
factors but insulin secretion is mainly influenced 
by genetic factor.13 The role of genetics has 
been studied extensively but much less when 
compared to studies regarding the role of 
environmental factors in T2DM. Genetic studies 
are challenging, considering that interethnic 
and interracial marriages are not uncommon, 
therefore it is difficult to conduct a study in a 
certain group of race. Studies in siblings of T2DM 
in one European ethnic group showed that phase 
1 and 2 insulin secretion was decreased with 
normal insulin sensitivity, whereas in African-
American ethnic groups it showed that insulin 
resistance was the first clinical manifestation that 
was observed, without the presence of pancreatic 
beta cell secretion dysfunction.14 A study by 
Rosenbaum, et al.14 in 2004 also reported a 
significant association between the family history 
of T2DM with impaired pancreatic beta cell 
function (not affected by body fat composition) 
without the presence of insulin resistance. In the 
study it was also reported that insulin resistance 
was mainly affected by increased in body fat 
composition.
The offspring of individuals with T2DM is 
a high-risk population for insulin resistance and 
has more severe cardiovascular risk factors, such 
as thicker intra-abdominal fat, higher systolic 
blood pressure, higher blood triglyceride and 
total cholesterol levels, lower HDL cholesterol 
levels and higher endothelium dependent 
vasodilatation (EDV), when compared with 
populations without family history of T2DM.15
Relatives (siblings and biological children) 
of T2DM subjects who are still normoglycemic 
also have higher insulin concentrations, lower 
peripheral glucose uptake and more accumulation 
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of fat tissue in the muscle compared to subjects 
without a history of T2DM.15,16
Studies regarding the prevalence of insulin 
resistance in T2DM-FDR population are still 
limited in Indonesia. Purnamasari, et al.17 have 
conducted a study in Jakarta and showed that 
the prevalence of insulin resistance in siblings 
of patients with T2DM by 26,67%. Kumar, et 
al.18 in India also conducted a study regarding 
the prevalence of insulin resistance in the FDR 
population and the results were 37.8%. However, 
prevalence of insulin resistance syndrome based 
on National Cholesterol Education Criteria Adult 
Treatment Panel III (NCEP ATP III) criteria in 
the adult general population in the United States 
is slightly lower at an approximate of 24%.19
S U B C L I N I C A L AT H E R O S C L E R O S I S 
DIAGNOSIS
Subclinical atherosclerosis is a manifestation 
of endothelial dysfunction and the onset of 
CVD. In these conditions, there has been an 
alteration in the blood vessel walls without any 
significant symptoms; therefore, at this stage 
an early intervention is expected to prevent 
cardiovascular events in the future.20
Several approaches are used to detect 
atherosclerosis as early as possible, both non-
invasive and invasive techniques. Invasive 
techniques have the advantage of a higher 
levels of precision and the ability to directly 
see abnormalities that occur in blood vessels. 
The disadvantages of this technique include 
discomfort for patients, higher costs, and higher 
risks of complication. While the non-invasive 
technique has relatively affordable cost and more 
convenient for patients.21
There are several non-invasive modalities that 
can be used to detect subclinical atherosclerosis 
including B-mode ultrasound examinations 
that can determine the thickness of the arterial 
intima-media arteries; high resolution magnetic 
resonance imaging (MRI) that is capable of 
evaluating the volume, plaque composition, 
and integrity of fibrous cap; and electron-beam 
computed tomography (EBCT) which can 
measure coronary artery calcification but cannot 
ascertain the tendency of plaque to rupture. 
Whereas invasive techniques include coronary 
angiography which is able to directly assess the 
coronary stenosis and intravascular ultrasound 
examination which is able to identify plaque size 
and composition that cannot be done through 
coronary angiography.21
The assessment of tunica intima media 
thickness of carotid artery by carotid 
ultrasound has been approved by the American 
Heart Association as a diagnostic tool for 
atherosclerosis.21 In addition, the measurement 
of the thickness of the carotid artery is an 
examination that can be performed quickly, 
without radiation exposure, non-invasive 
and at affordable costs.22 Carotid ultrasound 
examination had a sensitivity of 93.4% and a 
specificity of 94% to assess vascular calcification, 
blood vessel diameter, thickness of tunica intima 
media, assessing the presence of plaque and its 
expansion.23
THE CAROTID INTIMA MEDIA THICKNESS 
A S  C A R D I O VA S C U L A R  D I S E A S E 
PREDICTOR
The carotid intima-media thickness 
(CIMT) assessment is an examination of the 
thickness of the carotid artery wall, where 
atherosclerotic lesions in the common carotid 
artery depicted systemic atherosclerosis. This 
non-invasive procedure is relatively easy to 
perform and the results are comparable to other 
imaging techniques.23 Compared with coronary 
angiography, CIMT examination has a sensitivity 
and specificity in predicting coronary artery 
disease of 89.7% and 86.7%, respectively.24
The measurement carotid artery thickness 
has the prognosis to predict the incidence of 
stroke and coronary heart disease in the future. 
Hazard ratio of the risk of coronary artery disease 
between the mean thickness of CIMT ≥1 mm and 
<1 mm was 5.07 (in women) and 1.85 (in men). 
While the hazard ratio of stroke in the ratio of 
CIMT thickness ≥1 mm and ¸0.6 mm was 8.5 
(in women) and 3.6 (in men).25 A meta-analysis 
study involving 8 studies with a total of 37,197 
subjects showed that a 0.1 mm increase in the 
CIMT thickness of the carotid artery would 
increase the risk of myocardial infarction from 
10 to 15% and the risk of stroke from 13 to 
18%.26 Thus a thicker CIMT increases the risk 
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for cardiovascular events, such as myocardial 
infarction and stroke.
THE GENETIC ROLE OF ATHEROSCLEROSIS 
IN FIRST DEGREE RELATIVE OF TYPE 2 
DIABETES MELLITUS PATIENTS
In atherosclerosis, a prospective study in 
Caucasian ethnicity, which involved biological 
offsprings of patients with T2DM, who were 
normoglycemic and normotensive showed 
a more severe endothelial vasodilation and 
carotid artery thickening when compared to 
subjects without a family history of T2DM. 
This endothelial dysfunction is mediated by 
conditions of insulin resistance.27
Insulin resistance affects the renin 
angiotensin aldosterone system (RAAS). 
Therefore, the development of atherosclerosis 
is also be affected by the RAAS. Although 
there were several studies that has reported this 
relationship between RAAS and atherosclerosis 
in high-risk populations (hypertension, diabetes, 
cerebrovascular disease and arterial artery 
disease) and normal populations, the effect of 
RAA systems on atherosclerosis in the FDR of 
T2DM patients remain unclear.28,29
A study by Goldfine, et al. compared 
endothelial dysfunction and insulin resistance 
between 38 non-DM subjects with a history of 
T2DM in both parents and 38 control subjects. 
The study showed that the groups with family 
history of T2DM had a decreased endothelial 
dependent vasodilatation (EDV) response and 
further multiple regressions analysis showed 
that family history of DM was a significant 
determinant of EDV.30
Several studies have shown that mitochondria 
play an important role in the development of 
atherosclerosis. Mutations in mitochondrial 
DNA (mtDNA) at the nucleotide position 3243 
A to G (A3243G) are the main genetic causes 
of diabetes.31 Mitochondrial DNA has a somatic 
mutation rate of 5 to 20 times greater than nuclear 
DNA (nDNA), as mtDNA is located close to 
the respiratory chain that has the potential to 
produce reactive oxygen species (ROS). ROS 
is the main source of oxidative stress at cellular 
levels.32 Damage to mtDNA by ROS will result 
in the dysfunction of protein synthesis for 
the respiratory chain, in turn resulting in ATP 
production dysfunction and increased ROS 
leakage, which causing a vicious cycle because 
further mtDNA mutations will occur.
Insertion and deletion polymorphism of 
the angiotensin converting enzyme (ACE) 
is one of the polymorphisms associated with 
atherosclerosis.33 A study also found that p22phox, 
the NAD (P) H-oxidase subunit that produces 
ROS, also has polymorphisms that is associated 
with polymorphism in atherosclerosis.34
The population of FDR T2DM has earlier 
endothelial dysfunction and subclinical 
atherosclerosis when compared to non-FDR 
T2DM, despite remaining normotensive 
and normoglycemic. The role of genetics in 
atherosclerosis has been studied extensively 
through genetic polymorphisms studies, for 
example mtDNA polymorphism that has a 
protective role against atherosclerosis.
CAROTID INTIMA-MEDIA THICKNESS IN 
FIRST DEGREE RELATIVE OF TYPE 2 
DIABETES MELLITUS
In 2003, Pannacciulli, et al35 conducted 
the first study regarding the presence of 
atherosclerotic lesions in the population with 
FDR of T2DM. The study was conducted in Italy 
involving a total of 401 subjects aged 18-45 years 
with normal blood glucose concentrations. The 
results in the FDR group had a greater thickness 
of media intima than the non-FDR group. The 
study also showed a positive correlation between 
the thickness of the carotid media intima with 
age, BMI, abdominal circumference, triglyceride 
levels, systolic blood pressure, fasting blood 
glucose, 1-hour and 2-hour post prandial blood 
glucose and HOMA-IR, while the HDL showed 
a negative correlation.
Ahmad, et al.36 in 2006 studied a total of 76 
subjects who had normal blood glucose levels 
and were not obese in North India (38 subjects 
who had a family history of T2DM, 38 other 
subjects without a family history of T2DM). 
The results also indicate the same thing as the 
research conducted by Pannacciulli, et al. in 
2003. Besides the thickness of the intima media, 
which was significantly different between the 
two groups, the CRP levels and BMI in the FDR 
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of T2DM group were higher than the non-FDR 
group. The thickness of tunica intima media in 
this study had a positive correlation with systolic 
blood pressure, LDL cholesterol, post-prandial 
insulin levels and HOMA-IR.
In 2017, Kumar, et al.37 conducted similar 
study as Ahmed et al. in India. The difference was 
that they differentiated subjects with a history of 
parents (father or mother or both) who suffer from 
type 2 diabetes in relation to inflammation, insulin 
resistance, body mass index and thickness of the 
intima media. The result showed that individuals 
who have a history of both parents suffering from 
type 2 DM had worse glycemic status, higher 
CIMT compared to individuals who only have 
one parent suffering from type 2 DM.
An unpublished study in Indonesia by Abdaly, 
et al.38 showed that the average CIMT of the FDR 
group was 0.44 mm with a standard deviation of 
0.06 mm. While the mean CIMT of non-FDR 
group was lower than FDR subject, which was 
0.38 mm with a standard deviation of 0.05 mm 
(p=0.005). The results of this study are in line 
with previous studies that examined the thickness 
of the CIMT in the subject of FDR T2DM. This 
study shows that CIMT in FDR and non-FDR 
group in Indonesia have the lowest average when 
compared to subjects in Brazil, Italy, and India. 
This might be due to the higher body mass index 
of the Caucasians and Indians when compared to 
Malays.39,40
The body mass index (BMI) has been 
shown to be a positively correlated factor with 
carotid artery intima-media thickness. BMI 
and waist circumference have a relationship 
with the occurrence of insulin resistance. In 
obese subjects with insulin sensitivity, insulin 
plays a role in inhibiting the up-regulation of 
inflammatory markers circulating in the blood. 
Conversely, high levels of inflammatory markers 
due to impaired insulin inhibitory effects were 
found in obese subjects with insulin resistance.41 
The increase in acute phase protein as a result 
of insulin resistance will later lead to endothelial 
dysfunction and atherogenesis.42
CONCLUSION
Family history of the first degree of T2DM 
play an important role in the occurrence of 
subclinical atherosclerosis, especially at a young 
age in addition to other conventional factors for 
the occurrence of cardiovascular diseases such 
as hypertension, diabetes mellitus, dyslipidemia, 
smoking and obesity. Thickness of the carotid 
artery intima media as the surrogate marker of 
atherosclerosis has been shown to be thicker 
in the FDR group when compared to non-FDR 
group.
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